The molecular context of vulnerability for CDK9 suppression in triple wild-type melanoma. Guhan SM, Shaughnessy M, Rajadurai A, Taylor M, et al. J Invest Dermatol 2021 Mar 18. pii: S0022-202X(21)00977.

Read + Share

Amedeo Smart

Independent Medical Education

Guhan SM, Shaughnessy M, Rajadurai A, Taylor M, et al. The molecular context of vulnerability for CDK9 suppression in triple wild-type melanoma. J Invest Dermatol 2021 Mar 18. pii: S0022-202X(21)00977.
PMID: 33745909